Innoviva (INVA) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- $0.77
- EPS estimate
- $0.50
- EPS surprise
- +54.31%
- Revenue surprise
- +8.96%
- Revenue
- $100.3M
- Revenue estimate
- $92.0M
- Reported
- Aug 6, 2025
Innoviva reported Q2 2025 results on August 6, 2025. Earnings per share were $0.77, ahead of the $0.50 estimate by 54.31%. Revenue was $100.3 million, above the $92.0 million estimate. Compared with Q2 2024, EPS swung from a $0.55 loss to a profit, while revenue was nearly flat, up from $99.9 million.
Earnings in the table swing widely from quarter to quarter, more than revenue does. Annual EPS was $2.78 in 2021, $2.07 in 2022 and $2.18 in 2023, then dropped to $0.19 in 2024. Revenue was $391.9 million in 2021, $331.4 million in 2022, $310.5 million in 2023 and $358.7 million in 2024. The best quarter shown was Q3 2022, at $2.80 per share, and the worst was Q4 2022, a loss of $0.98. Three of the 20 quarters were losses, including Q1 2025 at $0.74 per share. The first half of 2025 brought $188.9 million of revenue, 6.5% more than a year earlier. Over the 20 quarters, Innoviva beat the EPS estimate ten times and missed ten times.
The table shows no report after Q2 2025. In the period covered, third-quarter results came out in late October or early November.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 6, 2025 | $0.50 | $0.77 | +54.31% | $100.3M | SEC |
| Q1 2025 | May 7, 2025 | $0.29 | −$0.74 | −351.87% | $88.6M | SEC |
| Q4 2024 | Feb 26, 2025 | $0.37 | $0.26 | −29.73% | $91.8M | SEC |
| Q3 2024 | Nov 6, 2024 | $0.27 | $0.02 | −92.45% | $89.5M | SEC |
| Q2 2024 | Jul 31, 2024 | $0.24 | −$0.55 | −334.04% | $99.9M | SEC |
| Q1 2024 | May 8, 2024 | $0.17 | $0.46 | +170.59% | $77.5M | SEC |
| Q4 2023 | Feb 29, 2024 | $0.23 | $0.76 | +230.43% | $85.8M | SEC |
| Q3 2023 | Nov 1, 2023 | $0.27 | $0.98 | +262.96% | $67.3M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.26 | $0.02 | −92.31% | $81.0M | SEC |
| Q1 2023 | May 9, 2023 | $0.23 | $0.42 | +82.61% | $76.4M | SEC |
| Q4 2022 | Feb 28, 2023 | $0.23 | −$0.98 | −535.56% | $65.8M | SEC |
| Q3 2022 | Nov 9, 2022 | $1.53 | $2.80 | +83.01% | $67.3M | — |
| Q2 2022 | Jul 27, 2022 | $1.47 | $0.05 | −96.59% | $108.2M | — |
| Q1 2022 | Apr 28, 2022 | $0.44 | $0.20 | −54.55% | $90.1M | — |
| Q4 2021 | Feb 9, 2022 | $0.41 | $0.14 | −65.85% | $107.7M | — |
| Q3 2021 | Oct 27, 2021 | $0.43 | $0.90 | +109.30% | $97.9M | — |
| Q2 2021 | Jul 28, 2021 | $0.29 | $0.90 | +210.34% | $100.8M | — |
| Q1 2021 | Apr 28, 2021 | −$0.01 | $0.84 | +8500.00% | $85.5M | — |
| Q4 2020 | Feb 3, 2021 | $0.40 | $0.48 | +20.00% | $90.5M | — |
| Q3 2020 | Oct 28, 2020 | $0.42 | $0.26 | −38.10% | $88.7M | — |
Quarterly revenue
Frequently asked questions
When did Innoviva (INVA) last report earnings?
Innoviva last reported on Aug 6, 2025, covering fiscal Q2 2025.
Did INVA beat earnings estimates?
Yes. Innoviva reported EPS of $0.77 for Q2 2025 against a $0.50 estimate — a 54.31% beat.
How much revenue did INVA report last quarter?
Innoviva reported $100.3M in revenue for Q2 2025, against a consensus estimate of $92.0M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.